Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) shot up 0.9% on Tuesday . The company traded as high as €48.48 and last traded at €48.48. 1,532,797 shares traded hands during mid-day trading, The stock had previously closed at €48.04.
Bayer Aktiengesellschaft Price Performance
The stock’s 50-day moving average price is €47.08 and its 200-day moving average price is €42.24. The company has a market capitalization of $48.94 billion, a price-to-earnings ratio of -55.62, a price-to-earnings-growth ratio of 36.39 and a beta of 0.83. The company has a quick ratio of 0.72, a current ratio of 1.04 and a debt-to-equity ratio of 129.90.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.
Further Reading
- Five stocks we like better than Bayer Aktiengesellschaft
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
